Market Indices
Sector Heatmap
KLRA — Kailera Therapeutics, Inc. Common Stock
NasdaqKailera Therapeutics, Inc. Common Stock
- O
- 10.48
- H
- 11.04
- L
- 9.85
- V
- 1.77M
KLRA — Latest News & Headlines
10 StoriesKailera Therapeutics (NASDAQ:KLRA) Stock Falls 5.6% - Should You Sell? - marketbeat.com
Kailera Therapeutics (NASDAQ:KLRA) Stock Falls 5.6% - Should You Sell? marketbeat.com
Three trials of a weekly obesity shot have finished enrolling; results are expected in mid-2028. - Stock Titan
Three trials of a weekly obesity shot have finished enrolling; results are expected in mid-2028. Stock Titan
Kailera Therapeutics Announces Phase 1 Ribupatide Data Showing Flexible Injection Sites and Additional Hengrui Pharma Clinical Presentations at EASD 2026 - quiverquant.com
Kailera Therapeutics Announces Phase 1 Ribupatide Data Showing Flexible Injection Sites and Additional Hengrui Pharma Clinical Presentations at EASD 2026 quiverquant.com
868,160 Shares of Kailera Therapeutics, Inc. $KLRA Acquired by State Street Corp - marketbeat.com
868,160 Shares of Kailera Therapeutics, Inc. $KLRA Acquired by State Street Corp marketbeat.com
An obesity shot showed similar drug levels after injection in the arm, thigh or abdomen. - Stock Titan
An obesity shot showed similar drug levels after injection in the arm, thigh or abdomen. Stock Titan
Kailera Therapeutics Completes Enrollment for Trial of Ribupatide to Treat Obesity - marketscreener.com
Kailera Therapeutics Completes Enrollment for Trial of Ribupatide to Treat Obesity marketscreener.com
KRSA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
KRSA Financials: Revenue Breakdown, Margins & Competitor Comparison Intellectia AI
Kailera Therapeutics (NASDAQ:KLRA) Hits New 12-Month Low - Here's Why - marketbeat.com
Kailera Therapeutics (NASDAQ:KLRA) Hits New 12-Month Low - Here's Why marketbeat.com
Kailera Therapeutics (KLRA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $KLRA - marketbeat.com
Kailera Therapeutics (KLRA) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $KLRA marketbeat.com
Kailera Therapeutics (NASDAQ:KLRA) Sets New 12-Month Low - Time to Sell? - marketbeat.com
Kailera Therapeutics (NASDAQ:KLRA) Sets New 12-Month Low - Time to Sell? marketbeat.com